Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Medco Spinoff Plan Revised; PBM Margins Look Healthier In 2003

  • News

Executive Summary

The one-year delay in Merck's Medco spinoff means that the pharmacy benefit manager will begin operations as a separately traded public company with a healthier gross margin

You may also be interested in...



Medco Is Meeting Merck Market Share Targets; Spin-Off Plan Moves Ahead

Merck's market share within the Medco customer base is running about 33% higher than the company's overall national market share

Medco Is Meeting Merck Market Share Targets; Spin-Off Plan Moves Ahead

Merck's market share within the Medco customer base is running about 33% higher than the company's overall national market share

Medco Lets Snow Reign: CEO David Snow Joins PBM From WellChoice

Medco Health's separation from Merck will be overseen by former WellChoice Chief Operating Officer David Snow

Table

View full table

Tags:
Latest Headlines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

Global Pharma Guidance Tracker – March 2024

See All
UsernamePublicRestriction

Register

PS041700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By